RAG1 and neoplasm: Notably, such treatments reduced tumour growth and weight in wild-type mice challenged with MC38 or B16-OVA tumour cells but not in Rag1–/– mice (Fig. 1b–d), suggesting the importance of adaptive immunity in mediating the anti-tumour effect of glutamine.